Effect of CYP2C8 inhibition by trimethoprim on the pharmacokinetics of rosiglitazone.

被引：0
|
作者：
Hruska, MW [1 ]
Amico, JA [1 ]
Frye, RF [1 ]
机构：
[1] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2003年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
92
引用
收藏
页码：1036 / 1036
页数：1
相关论文
共 50 条
  • [1] Effect of CYP2C8 genotype on rosiglitazone pharmacokinetics.
    Hruska, MW
    Cheong, JA
    Amico, JA
    Langaee, TY
    Frye, RF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P36 - P36
  • [2] Pharmacokinetics and pharmacodynamics of rosiglitazone in elation to CYP2C8 genotype
    Kirchheiner, Julia
    Thomas, Soju
    Bauer, Steffen
    Tomalik-Scharte, Dorota
    Hering, Ursula
    Doroshyenko, Oxana
    Jetter, Alexander
    Stehle, Simone
    Tsahuridu, Martina
    Meineke, Ingolf
    Brockmoeller, Juergen
    Fuhr, Uwe
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (06) : 657 - 667
  • [3] Effect of quercetin on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in healthy subjects
    Kim, KA
    Park, PW
    Kim, HK
    Ha, JM
    Park, JY
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (08): : 941 - 946
  • [4] Effect of multiple doses of montelukast on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in humans
    Kim, Kyoung-Ah
    Park, Pil-Whan
    Kim, Kyong Rae
    Park, Ji-Young
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (03) : 339 - 345
  • [5] The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects
    Hruska, MW
    Amico, JA
    Langaee, TY
    Ferrell, RE
    Fitzgerald, SM
    Frye, RF
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (01) : 70 - 79
  • [6] The effects of human CYP2C8 genotype and fluvoxamine on the pharmacokinetics of rosiglitazone in healthy subjects
    Pedersen, Rasmus S.
    Damkier, Per
    Brosen, Kim
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (06) : 682 - 689
  • [7] Trimethoprim and the CYP2C8*3 allele have opposite effects on the pharmacokinetics of pioglitazone
    Tornio, Aleksi
    Niemi, Mikko
    Neuvonen, Pertti J.
    Backman, Janne T.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (01) : 73 - 80
  • [8] Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide
    Tomalik-Scharte, Dorota
    Fuhr, Uwe
    Hellmich, Martin
    Frank, Dorothee
    Doroshyenko, Oxana
    Jetter, Alexander
    Stingl, Julia C.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (05) : 927 - 932
  • [9] EFFECT OF CYP2C9 AND CYP2C8 POLYMORPHISMS ON PHARMACOKINETICS OF IBUPROFEN ENANTIOMERS
    Abad-Santos, F.
    Ochoa, D.
    Prieto-Perez, R.
    Roman, M.
    Talegon, M.
    Rivas, A.
    Cabaleiro, T.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 23 - 23
  • [10] Discovery of a Novel Allelic Variant of CYP2C8, CYP2C8*11, in Asian Populations and Its Clinical Effect on the Rosiglitazone Disposition In Vivo
    Yeo, Chang-Woo
    Lee, Su-Jun
    Lee, Sang Seop
    Bae, Soo Kyung
    Kim, Eun-Young
    Shon, Ji-Hong
    Rhee, Byoung Doo
    Shin, Jae-Gook
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (04) : 711 - 716
12345